290 related articles for article (PubMed ID: 18951286)
1. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.
Coban G; Zencir S; Zupkó I; Réthy B; Gunes HS; Topcu Z
Eur J Med Chem; 2009 May; 44(5):2280-5. PubMed ID: 18692939
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
4. 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors.
Alpan AS; Gunes HS; Topcu Z
Acta Biochim Pol; 2007; 54(3):561-5. PubMed ID: 17823665
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
Rashid M; Husain A; Mishra R
Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
11. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
El-Nassan HB
Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bis-benzimidazole derivatives with alkylating moiety.
Bielawski K; Wołczyński S; Bielawska A
Pol J Pharmacol; 2004; 56(3):373-8. PubMed ID: 15215569
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
15. Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.
Kim JS; Gatto B; Yu C; Liu A; Liu LF; LaVoie EJ
J Med Chem; 1996 Feb; 39(4):992-8. PubMed ID: 8632422
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of novel benzimidazole-5-carboxylic acid derivatives and their transition metal complexes as topoisomerease II inhibitors.
Galal SA; Hegab KH; Hashem AM; Youssef NS
Eur J Med Chem; 2010 Dec; 45(12):5685-91. PubMed ID: 20884089
[TBL] [Abstract][Full Text] [Related]
17. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.
Abdel-Mohsen HT; Ragab FA; Ramla MM; El Diwani HI
Eur J Med Chem; 2010 Jun; 45(6):2336-44. PubMed ID: 20356655
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
19. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
